[go: up one dir, main page]

DE60139153D1 - 14189, eine humane kinase und deren verwendungen - Google Patents

14189, eine humane kinase und deren verwendungen

Info

Publication number
DE60139153D1
DE60139153D1 DE60139153T DE60139153T DE60139153D1 DE 60139153 D1 DE60139153 D1 DE 60139153D1 DE 60139153 T DE60139153 T DE 60139153T DE 60139153 T DE60139153 T DE 60139153T DE 60139153 D1 DE60139153 D1 DE 60139153D1
Authority
DE
Germany
Prior art keywords
kinase
nucleic acid
expression vectors
acid molecule
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60139153T
Other languages
English (en)
Inventor
Martin R Hodge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60139153D1 publication Critical patent/DE60139153D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60139153T 2000-08-18 2001-08-17 14189, eine humane kinase und deren verwendungen Expired - Lifetime DE60139153D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/641,690 US6759221B1 (en) 2000-08-18 2000-08-18 14189, a novel human kinase and uses thereof
PCT/US2001/025748 WO2002016563A2 (en) 2000-08-18 2001-08-17 14189, a human kinase and uses thereof

Publications (1)

Publication Number Publication Date
DE60139153D1 true DE60139153D1 (de) 2009-08-13

Family

ID=24573460

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139153T Expired - Lifetime DE60139153D1 (de) 2000-08-18 2001-08-17 14189, eine humane kinase und deren verwendungen

Country Status (7)

Country Link
US (3) US6759221B1 (de)
EP (1) EP1356040B1 (de)
AT (1) ATE435285T1 (de)
AU (1) AU2001288284A1 (de)
DE (1) DE60139153D1 (de)
ES (1) ES2327903T3 (de)
WO (1) WO2002016563A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003371A2 (en) * 2003-06-17 2005-01-13 University Of Virginia Patent Foundation Erk7 and erk8, novel diagnostic markers for cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003501038A (ja) 1999-05-28 2003-01-14 スージェン・インコーポレーテッド 蛋白質キナーゼ
US6656698B1 (en) * 1999-06-30 2003-12-02 Millennium Pharmaceuticals, Inc. 12832, a novel human kinase-like molecule and uses thereof
EP1240194A2 (de) 1999-11-24 2002-09-18 Sugen, Inc. Protein kinasen und protein kinase-ahnliche enzyme identifiziert durch genomisches sequenzieren
EP1261721A1 (de) 2000-03-08 2002-12-04 MERCK PATENT GmbH Menschlische ,extrazellulare, signlregulierte kinase
US6416990B2 (en) 2000-06-06 2002-07-09 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US6413756B2 (en) * 2000-06-06 2002-07-02 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
CA2420105A1 (en) 2000-08-31 2002-03-07 Incyte Genomics, Inc. Human kinases

Also Published As

Publication number Publication date
WO2002016563A2 (en) 2002-02-28
ATE435285T1 (de) 2009-07-15
US20040146939A1 (en) 2004-07-29
EP1356040B1 (de) 2009-07-01
ES2327903T3 (es) 2009-11-05
US20110110915A1 (en) 2011-05-12
US6759221B1 (en) 2004-07-06
WO2002016563A3 (en) 2002-10-31
EP1356040A2 (de) 2003-10-29
US7759085B2 (en) 2010-07-20
AU2001288284A1 (en) 2002-03-04

Similar Documents

Publication Publication Date Title
DE60033293D1 (de) Neue b7-4 moleküle und deren verwendungen
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
EP1009752A4 (de) Neue moleküle aus der familieder tango-77-ähnlichen proteine und ihre verewendungen.
ATE419358T1 (de) Gebrauchsverfaheren eines neuen lysyloxidase- verwandten proteins
WO2002044354A3 (en) Molecules of the card-related protein family and uses thereof
WO2000052047A3 (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
WO2001000826A3 (en) Novel molecules of the card-related protein family and uses thereof
DE60140559D1 (de) 32144, eine humane fettsäureamid-hydrolase und deren verwendungen
WO2001061005A3 (en) Molecules of the pyrin domain protein family and uses thereof
DE60237613D1 (de) Neue pgc-1-isoformen und deren verwendungen
DE60142356D1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
WO2002085939A8 (en) Novel molecules of the card-related protein family and uses thereof
DE60138952D1 (de) 16836, ein mitglied der humanen phospholipase c familie und seine verwendungen
DE60139153D1 (de) 14189, eine humane kinase und deren verwendungen
WO2001064894A3 (en) Human phospholipid scramblase-like molecules and uses thereof
WO2001090365A3 (en) Human protein kinase '13305' and uses therefor
WO2001059065A3 (en) Novel molecules of the card-related protein family and uses thereof
WO2001081588A3 (en) 2246, novel protein kinase molecules and uses therefor
WO2001064919A3 (en) 18036, a novel calpain-like protease and uses thereof
DE60237236D1 (de) Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür
WO2001068806A3 (en) 26934, a novel cytidine deaminase-like molecule and uses thereof
WO2001040468A3 (en) Molecules of the card-related protein family and uses thereof
DE60136832D1 (de) Atcr-1, eine humane acyltransferase und verwendungen davon
DE60125569D1 (de) 13245, eine neue, humane protein kinase vom typ myotonische dystrophie protein kinase und anwendungen davon
WO2003035840A3 (en) 69583 and 85924, novel human protein kinase family members and uses therefor

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE

8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1356040

Country of ref document: EP

Representative=s name: FERDINAND KOEHLER, DE